Serum-based protein biomarkers such as cancer antigen-125 (CA-125) and cancer antigen-15.3 (CA 15.3) are commonly used for monitoring breast cancer patients, but these proteins are also found in the serum of individuals without cancer; therefore, they are not useful for diagnosis [41]. This evidence concerns the gene MUC16 and breast cancer.